| JVP | [POMD P 49 - 52] 1) Jugular Vein Pressure 2) Jugular Venous Pulse ... |
|---|---|
| PIP | paralytic infantile paralysis; peak inflation pressure, peak inspiratory pressure; periodic interim ... |
| PPT | parietal pleural tissue; partial prothrombin time; peak-to-peak threshold; Pfeiffer-Palm-Teller [syn... |
| MAbs | Monoclonal Antibodies |
| MG | 1) Myasthenia Gravis 2) MonoGlyceride 3) Monoclonal Gammop... |
| peak VO2 | Peak oxygen consumption |
|---|---|
| peak VO(2) | Peak oxygen uptake |
| P-P | peak to peak |
| BMG | benign monoclonal gammopathy |
| Bi-MAbs | Bispecific monoclonal antibodies |
| monoclonal peak | A narrow band visible on electrophoresis or an abnormal arc seen on immunoelectrophoresis, thought to represent immunoglobulin of one cell clone. (05 Mar 2000) |
|---|
| antibodies, monoclonal | Antibodies produced by clones of cells such as those isolated after hybridization of activated b lymphocytes with neoplastic cells. These hybrids are often referred to as hybridomas. (12 Dec 1998) |
|---|---|
| monoclonal | 1. <cell biology> Used of a cell line whether within the body or in culture to indicate that it has a single clonal origin. 2. <immunology> Monoclonal antibodies are produced by a single clone of hybridoma cells and are therefore a single species of antibody molecule. (18 Nov 1997) |
| monoclonal antibodies | Identical antibodies that are made in large amounts in the laboratory. Doctors are studying ways of using monoclonal antibodies to treat leukaemia. (12 Dec 1998) |
| monoclonal antibody | <immunology, molecular biology> A substance, usually a protein, which can be synthsised in the laboratory in pure form by a single clone (population) of cells. These antibodies can be made in large quantities and have a specific affinity for certain target molecules called antigens which can be found on the surface of cells and those that are malignant. Monoclonal antibodies are currently being investigated as a possible form of cancer treatment although their benefit has not be fully proven. (16 Dec 1997) |
| monoclonal gammopathies, benign | Conditions characterised by the presence of a monoclonal serum (or urine) protein without clinical manifestations of plasma cell dyscrasia. (12 Dec 1998) |
| monoclonal immunoglobulin | A homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells and which, during electrophoresis of serum, appears as a narrow band or "spike"; it is characterised by heavy chains of a single class and subclass, and light chains of a single type. Synonym: M protein, monoclonal protein, paraprotein. (05 Mar 2000) |
| monoclonal protein | A homogenous immunoglobulin resulting from the proliferation of a single clone of plasma cells and which, during electrophoresis of serum, appears as a narrow band or "spike"; it is characterised by heavy chains of a single class and subclass, and light chains of a single type. Synonym: M protein, monoclonal protein, paraprotein. (05 Mar 2000) |
| biclonal peak | Two narrow electrophoretic bands thought to represent immunoglobulin of two cell lines. (05 Mar 2000) |
| peak | The top or upper limit of a graphic tracing or of any variable. Origin: M.E. Peke, pike, fr. Sp. Pico, beak, fr. L. Picus, magpie (05 Mar 2000) |
| peak expiratory flow | The maximum flow at the outset of forced expiration, which is reduced in proportion to the severity of airway obstruction, as in asthma. (05 Mar 2000) |
| peak expiratory flow rate | Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr. (12 Dec 1998) |
| peak flow | <chest medicine, physiology> The maximum flow rate of air breathed out during forced expiration. (15 Nov 1997) |
| peak flow rate | Maximum urinary flow rate during voiding as measured by a uroflowmeter. (05 Mar 2000) |
| peak magnitude | The greatest amplitude. (05 Mar 2000) |
| peak plasma drug concentration | <pharmacology> The highest level of drug that can be obtained in the blood usually following multiple doses. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|